{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:46:00Z","timestamp":1777527960895,"version":"3.51.4"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2021,5,19]]},"abstract":"<jats:p>The World Health Organization (WHO) has targeted measles for global eradication through mass immunization. For effective monitoring of eradication targets, high-quality surveillance is needed.<\/jats:p>","DOI":"10.1128\/jcm.03161-20","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T13:00:29Z","timestamp":1615899629000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":28,"title":["Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Measles Virus-Specific IgM Antibodies"],"prefix":"10.1128","volume":"59","author":[{"given":"Joanne","family":"Hiebert","sequence":"first","affiliation":[{"name":"Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Zubach","sequence":"additional","affiliation":[{"name":"Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen L.","family":"Charlton","sequence":"additional","affiliation":[{"name":"Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada"},{"name":"Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"},{"name":"Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayne","family":"Fenton","sequence":"additional","affiliation":[{"name":"Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham A.","family":"Tipples","sequence":"additional","affiliation":[{"name":"Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada"},{"name":"Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada"},{"name":"Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada"},{"name":"Department of Microbiology, Immunology, and Infectious Disease, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0844-2634","authenticated-orcid":true,"given":"Alberto","family":"Severini","sequence":"additional","affiliation":[{"name":"Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/378499"},{"key":"e_1_3_2_3_2","unstructured":"Public Health Agency of Canada. 2013. Elimination of measles rubella and congenital rubella syndrome in Canada: documentation and verification report. Public Health Agency of Canada https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/vaccine-preventable-diseases\/elimination-measles-rubella-congenital-rubella-syndrome-canada-documentation-verification-report.html. Accessed 17 November 2020."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6848a1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis923"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v40i12a04"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v40i12a05"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v41i07a02"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2307.161145"},{"key":"e_1_3_2_10_2","unstructured":"World Health Organization. 2012. Global measles and rubella strategic plan: 2012\u20132020. https:\/\/apps.who.int\/iris\/rest\/bitstreams\/53400\/retrieve. Accessed 13 August 2020."},{"key":"e_1_3_2_11_2","unstructured":"World Health Organization. 2018. Manual for the laboratory-based surveillance of measles rubella and congenital rubella syndrome 3rd ed. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/laboratory\/manual\/en\/. Accessed August 13 2020."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-2516(96)80583-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.99-104.2000"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.41.10.4790-4792.2003"},{"key":"e_1_3_2_15_2","unstructured":"DiaSorin. 25 July 2017. Press release: DiaSorin to acquire ELISA immunodiagnostic business portfolio and associated assets from Siemens Healthineers. https:\/\/diasoringroup.com\/sites\/diasorincorp\/files\/allegati_pressrel\/pr_diasorin_-_acquisition_of_siemens_elisa_eng_1.pdf."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"e_1_3_2_17_2","unstructured":"Public Health Agency of Canada. 2018. Part 4. Active vaccines in Canadian Immunization Guide. Version dated October 2018. https:\/\/www.canada.ca\/en\/public-health\/services\/canadian-immunization-guide.html. Accessed 14 August 2020."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2009.02581.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21630"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12413"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2013.10.027"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2016.08.018"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1386-6532(99)00051-7"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pis133"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.04.009"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v41i07a03"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv048"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v40i12a01"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v41i07a01"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v42i07a01"},{"key":"e_1_3_2_31_2","unstructured":"Public Health Agency of Canada. 2017. Measles surveillance in Canada: 2016. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/measles-surveillance-canada-2016.html. Accessed 13 August 2020."},{"key":"e_1_3_2_32_2","unstructured":"Public Health Agency of Canada. 2019. Measles surveillance in Canada: 2017. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/measles-surveillance-canada-2017.html. Accessed 13 August 2020."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v46i04a04"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181172"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.03161-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.03161-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:03:36Z","timestamp":1646485416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.03161-20"}},"subtitle":[],"editor":[{"given":"Angela M.","family":"Caliendo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,5,19]]}},"alternative-id":["10.1128\/JCM.03161-20"],"URL":"https:\/\/doi.org\/10.1128\/jcm.03161-20","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"2020-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e03161-20"}}